Defense Backlog Growth Signals Demand, But TTMI Valuation Remains Extreme

What happened

Zacks reports that TTM Technologies has a $1.7 billion defense backlog and a pipeline exceeding $7 billion, reflecting strong demand in aerospace and defense. The company's advanced manufacturing investments, including the Syracuse facility, are designed to capitalize on this growth. However, the latest DeepValue analysis indicates that the stock trades at approximately 52 times earnings and 23 times EV/EBITDA, with a DCF-based intrinsic value of only $6.73 per share versus a current price of $67.63. This valuation implies that the market has already priced in an extremely optimistic scenario, leaving little margin of safety. Consequently, while the defense pipeline is positive, it does not alter the assessment that TTMI is significantly overvalued at current levels.

Implication

TTMI's defense backlog and pipeline provide tangible evidence of near-term revenue visibility and long-term growth potential in A&D. However, the stock's current multiple of 52x earnings and EV/EBITDA of 23x suggests that the market has already priced in an extremely optimistic outcome, with a DCF-implied value less than one-tenth of the share price. This leaves minimal room for error and increases the risk of a sharp correction if execution or demand falters. Investors should wait for a meaningful valuation reset or a sustained improvement in free cash flow and margins before considering an entry. Until then, the risk/reward is skewed to the downside, and a cautious stance is warranted.

Thesis delta

The article highlights $1.7B in defense backlog and a $7B+ pipeline, reinforcing the operational strength noted in the master report. However, this news does not change the core thesis that TTMI is overvalued; it may even exacerbate the risk of over-optimism. The STRONG SELL rating remains intact, with valuation metrics showing no improvement and the DCF value still far below market price.